Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice

This publication has 18 references indexed in Scilit:

• Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
  Cancer Chemotherapy and Pharmacology, 1995
• A New Water‐soluble Camptothecin Derivative, DX‐8951f, Exhibits Potent Antitumor Activity against Human Tumors in vitro and in vivo
  Japanese Journal of Cancer Research, 1995
• Topoisomerase I inhibitors and other new cytotoxic drugs
  European Journal Of Cancer, 1995
• A Limited Sampling Model for Estimating Pharmacokinetics of CPT‐11 and Its Metabolite SN‐38
  Japanese Journal of Cancer Research, 1995
• Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11
  Japanese Journal of Cancer Research, 1995
• A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38
  Japanese Journal of Cancer Research, 1995
• Effects of CPT‐11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno‐transplanted neuroblastoma
  Medical and Pediatric Oncology, 1994
• Effects of newly introduced chemotherapeutic agents on a cytogenetically highly malignant neuroblastoma, xenotransplanted in nude mice
  Journal of Pediatric Surgery, 1993
• Effects of cyclophosphamide, cis-platinum, nitrosourea (ACNU), melphalan, and dacarbazine on a cytogenetically highly malignant neuroblastoma xenograft
  Medical and Pediatric Oncology, 1986
• Nude mouse xenograft study for treatment of neuroblastoma: Effects of chemotherapeutic agents and surgery on tumor growth and cell kinetics
  Journal of Pediatric Surgery, 1984